Tuesday, april 27 anatomy - Experimental Biology

pathology/Pharmacology
A372 954.14 Bowel morphologic evaluation in experimental
administration of wine and a pesticide. K.P. Cavalcanti, A.P.
Gurgel, T. Mendes, P. Barreto, I.A. Souza, N.T. Filho and
A.S. Cabrita. Fac. of Med., Univ. of Coimbra, Portugal and Fed.
Univ. of Pernambuco, Brazil.
A373 954.15 VEGF xxx
b is relatively downregulated in
malignant neuroblastoma but not in benign ganglioneuroma.
M. Peiris, D.O. Bates and P. Ramani. Univ. of Bristol.
A374 954.16 Low immunohistochemical expression of
MGMT in ACTH secreting pituitary tumors of patients with
Nelson syndrome. F. Salehi, B.W. Scheithauer, V.J. Moyes,
W.M. Drake, L. Syro, B. Manoranjan, S. Sharma, E. Horvath
and K. Kovacs. St. Michael’s Hosp., Univ. of Toronto, Mayo
Clin., St. Bartholomew’s Hosp., London and Hosp. Pablo Tobon
Uribe, Medellin, Colombia.
Tuesday
A375 954.17 Immunoexpression of endoglin and CD-34
in various human pituitary adenoma types. F. Rotondo, S.
Sharma, B.W. Scheithauer, M. Cusimano and K. Kovacs. St.
Michael’s Hosp., Univ. of Toronto and Mayo Clin.
A376 954.18 Sensory dysesthesia: rare presentation of
subependymoma. M. Kurukumbi, G. Ramidi, S. Samineni, A.
Jayam-Trouth and A. Dabi. Howard Univ. Hosp.
A377 954.19 The IKK inhibitor BMS345541 affects aurora
kinase expression in human melanoma. R. Splittgerber, Y-J.
Su, Y.M. Thu, D. Raman and A. Richmond. Vanderbilt Univ.
Pharmacology and Experimental Therapeutics
955. Vascular Function in Hypertension
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:30 p m-2:45 p m
C1 955.1 Adventitial infiltration of activated macrophages
in mesenteric arteries of DOCA-salt rats. L.V. Thang and J.J.
Galligan. Michigan State Univ.
C2 955.2 Expression of Ang 1-7 receptor (MAS receptor)
in aortic tissue during pregnancy-induced hypertension in rats.
L. Anguiano-Robledo, M.A. Avila, B. Vazquez-Cruz and P.
Lopez-Sanchez. Esc. Superior de Med.-IPN, Mexico City and
FES Iztacala-UNAM, Mexico.
C3 955.3 Renin/prorenin receptor decreased expression
in heart during pregnancy-induced hypertension in rats. P.
Lopez-Sanchez, E.M. Lopez, M.A. Avila and L. Anguiano-
Robledo. Esc. Superior de Med.-IPN, Mexico City.
C4 955.4 Expression of renin/prorenin receptor is
decreased in vessels and kidney during pregnancy-induced
hypertension in rats. R. Esteban, L. Anguiano-Robledo, J.A.
Vela and P. Lopez-Sanchez. Esc. Superior de Med.-IPN,
Mexico City.
C5 955.5 Arterial function and flow related arterial
remodeling during DOCA-salt hypertension. P. Lemkens, J.
Nelissen, G.E. Fazzi, B.J.A. Janssen, J.G.R. De Mey and
P.M.H. Schiffers. Maastricht Univ., Netherlands.
C6 955.6 Increased catecholamine content and release
from adrenal chromaffin cells of DOCA-salt hypertensive rats.
M.J. Fhaner, G. Swain and J.J. Galligan. Michigan State
Univ.
C7 955.7 Role of TLR4 expression in experimental
hypertension. G.F. Bomfim, R.C. Tostes, Z. Fortes and M.H.
Carvalho. Univ. of São Paulo.
C8 955.8 Influence of ACE gene polymorphisms on
antihypertensive efficacy, left ventricular mass and proteinuria
in children undergoing ramipril monotherapy. R. Buescher,
I. Finkelberg and P.F. Hoyer. Univ. of Duisburg-Essen,
Germany.
C9 955.9 Differential alteration of sympathetic
norepinephrine transporter in mesenteric arteries and veins
in DOCA-salt hypertensive rats. S. Sangsiri, H. Dong, G.M.
Swain, J.J. Galligan and H. Xu. Michigan State Univ.
C10 955.10 Beneficial vascular effect of a non-selective
PPAR activator in aorta of spontaneously hypertensive rats. C.
Qu, S.W.S. Leung, P.M. Vanhoutte and R.Y.K. Man. Univ. of
Hong Kong.
C11 955.11 Mitogen-activated protein kinase phosphatase-1
is low in dorsal medulla of hypertensive (mRen2)27
transgenic rats. M. Nautiyal, E.A. Tallant, M.C. Chappell and
D.I. Diz. Wake Forest Univ. Sch. of Med.
956. Vascular Endothelial Function:
General
Poster
Tu e. 7:30 a m—An a h e i m Co n v e n t i o n Ce n t e r, Ex h i b it Ha l l CD
Presentation time: 12:30 p m-2:45 p m
C12 956.1 Myogenic constriction occurs in the absence
of a detectable increase in pLC20 in the presence of agonistinduced
tone. A.F. El-Yazbi, E.J. Walsh, M.P. Walsh and W.C.
Cole. Univ. of Calgary.
C13 956.2 Angiotensin (1-7) induced inhibition of the
nerve-stimulation induced release of norepinephrine and
neuropeptide Y from the rat mesenteric arterial bed: role of
prostacyclin. J.M. Murray, H. Macarthur and T.C. Westfall.
Saint Louis Univ.
C14 956.3 Regulation of vascular endothelial signaling
with therapeutic nanoparticles that target the NF-kB pathway.
H. Pan, G.M. Lanza and S.A. Wickline. Washington Univ. Sch.
of Med.
C15 956.4 Loss of endothelial focal adhesion kinase
in mice causes lung vascular leak, alveolar destruction and
inflammation. T.L. Thennes, M. Tauseef, N. Knezevic, J.R.
Göthert, T-L. Shen, J-L. Guan, D.A. Cheresh and D. Mehta.
Univ. of Illinois at Chicago, Univ. Hosp. of Essen, Germany,
Natl. Taiwan Univ., Univ. of Michigan and UCSD.
C16 956.5 Inhibition of TNF-a-induced reactive oxygen
species generation, cell adhesion molecule expression and
NF-kB activation by 5-hydroxymethylfurfural in human umbilical
vein endothelial cells. H.K. Kim, H.J. Kim, J.K. Park, E.N. Lee,
S-O. Oh, S-Y. Baek, B-S. Kim, Y-W. Choi and S. Yoon. Sch. of
Med. and Col. of Natural Resources and Life Sci., Pusan Natl.
Univ., Republic of Korea.
290